MDR-TB: Clinical Trials

1 trial for MDR-TB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow MDR-TB: new trials by email Literature Review of MDR-TB trials Research Report on MDR-TB

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)
Acetohydroxamic Acid, Placebo - Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis
Phase 2Not yet recruitingShanghai Pulmonary Hospital, Shanghai, China1202026-02-212026-02-06

Narrower conditions

Tuberculosis, Multidrug-Resistant (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Mycobacterium Infections (1)  ·  Tuberculosis (1)

Interventions

acetohydroxamic acid (1)

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China (1)

Countries

China (1)